Ivercop® Tablets

Ivermectin 6mg / 12mg

4.50 out of 5

(2 customer reviews)

From USD $27.00 (EUR €22.41)

Brands:Menarini

Ivermectin is an anthelmintic (anti-parasite) used to treat infections caused by certain parasites. Ivermectin systemic is used in the treatment of Ascariasis, Cutaneous Larva Migrans, Filariasis, Elephantiasis Onchocerciasis, River Blindness, Scabies, Strongyloidiasis. In veterinary medicine, it is used to prevent and treat heartworm and acariasis, among other indications.

Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials. Evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease.

Size: 10 Tablets
Brand name: Stromectol, Heartgard, Mectizan
Clear
TitleRangeDiscount
Items:2 - 4 5%
Items:5 - 8 10%
Items:9 + 15%

Description

What is Ivermectin Tablets?

Ivermectin is used in the treatment of certain worm infections. It is used to treat river blindness (onchocerciasis) and a certain type of diarrhea (strongyloidiasis). It may also be used for some other kinds of worm infections. Ivermectin appears to work by paralyzing and then killing the offspring of adult worms. It may also slow down the rate at which adult worms reproduce. This results in fewer worms in the skin, blood, and eyes.

Ivercop® contains tablets 6mg and 12mg contain ivermectin, an anthelmintic used to treat parasitic infections caused by nematode worms including strongyloidiasis and lymphatic filariasis; also scabies caused by an ectoparasitic mite. Parasites are organisms that survive by living off another organism called the host. Some parasites may irritate, but otherwise, do not make their host sick. However, in many cases, the parasite affects many areas of the host’s body, making the host severely ill. Ivercop® tablets 6mg/12mg are used to treat parasitic infections caused by parasitic worms and ectoparasites like scabies, to relieve symptoms and prevent the spread of infection.


Parasitic worms

Strongyloidiasis is an infection caused by the nematode Strongyloides stercoralis an intestinal parasite belonging to the hookworm group of roundworms. Infection is by direct contact with contaminated soil. The larval worms enter the bloodstream, migrate to the lungs, and are then swallowed. Once in the host intestine, the larvae mature into adults and produce eggs, which hatch, and the next generation of larvae are excreted in the feces or migrate to other parts of the body. In this way, the larvae can re-infect the same host. Strongyloidiasis symptoms include a rash at the site of larval penetration, usually the feet. Also, gastrointestinal symptoms (diarrhoea, abdominal pain, nausea, and vomiting); other symptoms include low-grade fever, coughing and wheezing, due to the migration of larvae through the lungs. The infection can be more severe if the parasite spreads throughout the body.

Lymphatic filariasis, also known as elephantiasis, is caused by the thread-like nematode worm Wuchereria bancrofti. This parasite is carried by mosquitos and transmitted by a bite from an infected mosquito. This allows the larvae to enter the bloodstream and migrate to the lymph vessels. The larvae mature into adults, mate, and produce and microfilariae, which circulate in the blood, ready to infect another mosquito when it bites. In the mosquito, microfilariae grow into adults, to begin the life cycle again. Symptoms of lymphatic filariasis include lymphoedema, due to obstruction of the lymphatic system. This causes swelling in the arms, legs, or genitals, which can be painful and disfiguring.

Other intestinal nematode parasites include roundworm (ascariasis), whipworm (Trichuriasis), and pinworm (Enterobiasis).


Scabies

Scabies is a contagious ectoparasitic infection, caused by the parasitic mite Sarcoptes scabiei, transmitted by direct skin contact. The scabies mite burrows into the skin, causing itching as it burrows, which can be intense and is often worse at night. Within two to six weeks after infection, the mite can cause an allergic reaction. Symptoms include a rash, seen as small red bumps on the limbs and trunk, which are usually very itchy; also, nodules in the groin or armpit. Burrow lines can also be seen at the site of infection, generally between the fingers, on the skin of the hands, feet, wrist, elbows, buttocks, and genitals. If left untreated, scabies infection can cause secondary complications. These include impetigo (infection and inflammation of superficial skin cells), and cellulitis (inflammation of the lower dermal or subcutaneous skin layers).


Rosacea treatment with oral Ivermectin

Ivermectin is an effective treatment for moderate to severe pustular rosacea, but it has not been studied in patients with milder forms of rosacea. Ivermectin represents a unique treatment for reducing inflammatory lesions of rosacea and is thought to exert its benefit via dual mechanisms. First, ivermectin has anti-inflammatory activity, decreasing both the cellular and humoral immunity pathways that are thought to be involved in the development of rosacea. In addition, ivermectin is a vermicidal agent, killing Demodex mites that have been implicated in rosacea pathophysiology and may drive inflammation.

The etiology and pathogenesis of rosacea are not fully understood. It is thought to be caused by a combination of factors, including augmented immune response, neuroimmune dysregulation, and vast regulatory alterations. There is growing evidence that Demodex mites play a role in the etiology and pathogenesis of rosacea. The density of Demodex organisms has been found to be greater in areas affected by rosacea than in healthy skin, and these mites have been found in a significant proportion of patients with rosacea. Good response to acaricidal agents has been reported. In addition, Demodex mites have started to gain recognition as one of the numerous factors that trigger the expression of Toll-like receptors 2 (TLR-2), giving rise to the exacerbated immune response observed in patients with papulopustular rosacea.

Ivermectin is an antiparasitic agent that has been widely used since 1988 for the oral treatment of filariasis and other parasitic infections. Ivermectin not only has an antiparasitic effect but also has an immunomodulatory and anti-inflammatory effect by inhibiting the lipopolysaccharide-induced production of cytokines. The use of topical ivermectin for the treatment of rosacea was approved by the US Food and Drug Administration in 2014 and by the European Medicines Agency in 2015. Oral ivermectin has also been successfully used, without formal indication, in the treatment of demodicosis, in both immunosuppressed and immunocompetent patients. Oral ivermectin has also been used, with satisfactory results, in 2 healthy patients with papulopustular rosacea; in 1 case, the patient received 3mg/d for 8 days in association with 5% topical permethrin 3 times a week, and in the other case, a child with severe oculocutaneous rosacea received a single dose of 250μg/kg.

Rosacea can be treated but not cured. Like all chronic diseases, rosacea requires safe, effective treatment that achieves long periods of remission. In patients who have received oral ivermectin for the treatment of systemic infections, adverse effects have been very rare (<1%) over the past few decades and appear to be related to parasite load. Similarly, no serious adverse effects have been reported when a single dose (200μg/kg) has been given for the treatment of scabies. However, only short-term safety studies have been carried out and it is not known whether repeated treatment is safe. Our patient had no adverse effects and prolonged remission was achieved with a single dose, but prospective studies with large groups of patients are needed in order to confirm our results.


How does Ivermectin work (Stromectol generic)?

Ivermectin dispersible tablets 6mg/12mg contains ivermectin, an anthelmintic that is used to treat parasitic infections. Ivermectin in Ivercop is derived from the avermectins. These are a series of drugs that are isolated from the fermentation of the soil bacteria Streptomyces avermitilis. The avermectins are used to treat a variety of parasitic diseases.

Ivermectin in Ivercop tablets works by interacting directly and specifically with the nervous system of the parasite but does not affect mammals. Ivermectin in Ivercop tablets 6mg/12mg binds strongly to specific receptors in the parasite nerve and muscle cells that are only found in invertebrate cells. These are the gamma-aminobutyric acid (GABA) and glutamate (GluCl) regulated chloride channels. Ivermectin binding to these channels causes paralysis and death of the parasite. Ivermectin is effective in interrupting the infectious cycle and helping to prevent the spread of infection.


What do Ivermectin Tablets contain?

Ivercop contains the active ingredient ivermectin (6mg and 12mg), an anthelmintic used to treat various parasitic diseases.


What are the side effects of Ivermectin Tablets (Stromectol generic)?

Common side effects when taking Ivermectin include transient tachycardia (fast heart rate), flushing, nausea, diarrhoea, nausea, vomiting, abdominal pain, itching skin rash, asthenia (weakness), light-headedness, dizziness, drowsiness, vertigo, tremor. Have a talk with your primary healthcare physician before taking Ivermectin tablets 6mg or 12mg so that you have a full understanding of what this medicine is for and how to use it. There are some reasons for not taking a medication; these are called contraindications, and for Ivercop, you should consult your doctor to get more information.


Efficacy of Ivermectin treatment of COVID-19 infection

Ivermectin is a broad-spectrum anti-parasitic agent, included in the WHO essential medicines list for several parasitic diseases. It is used in the treatment of onchocerciasis (river blindness), strongyloidiasis, and other diseases caused by soil-transmitted helminthiasis. It is also used to treat scabies. We assessed the efficacy of ivermectin treatment in reducing mortality, in secondary outcomes, and in chemoprophylaxis, among people with, or at high risk of, COVID-19 infection. More you may read in this article.

Additional Information